1. Home
  2. NODK vs DRTS Comparison

NODK vs DRTS Comparison

Compare NODK & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NODK

NI Holdings Inc.

N/A

Current Price

$14.29

Market Cap

279.8M

Sector

Finance

ML Signal

N/A

Logo Alpha Tau Medical Ltd.

DRTS

Alpha Tau Medical Ltd.

HOLD

Current Price

$5.03

Market Cap

300.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NODK
DRTS
Founded
1946
2015
Country
United States
Israel
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
279.8M
300.2M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
NODK
DRTS
Price
$14.29
$5.03
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.00
AVG Volume (30 Days)
13.5K
159.0K
Earning Date
11-07-2025
11-20-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.11
N/A
Revenue
$297,973,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$126.12
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.01
$2.30
52 Week High
$17.06
$5.10

Technical Indicators

Market Signals
Indicator
NODK
DRTS
Relative Strength Index (RSI) 70.95 71.25
Support Level $13.31 $3.84
Resistance Level $14.08 $5.07
Average True Range (ATR) 0.39 0.37
MACD 0.10 0.15
Stochastic Oscillator 100.00 92.16

Price Performance

Historical Comparison
NODK
DRTS

About NODK NI Holdings Inc.

NI Holdings Inc is a stockholding company. The company's operating segments include private passenger auto insurance, non-standard auto insurance, home and farm insurance, crop insurance, commercial insurance, and others. The company operates only in USA.

About DRTS Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.

Share on Social Networks: